GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CellSeed Inc (TSE:7776) » Definitions » Deferred Policy Acquisition Costs

CellSeed (TSE:7776) Deferred Policy Acquisition Costs


View and export this data going back to 2010. Start your Free Trial

What is CellSeed Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


CellSeed Business Description

Industry
Traded in Other Exchanges
N/A
Address
Katsura-Bldg, 4F, 3-61, Haramachi, Shinjuku-ku, Tokyo, 162-0053, JPN
CellSeed Inc is a Japanese biotechnology company. The company is involved in the research, development, marketing, and sale of cell-sheet regenerative medicines, such as epithelial cell sheet for corneal and esophageal regeneration; regenerated cardiac patch to treat heart diseases; cell sheet for periodontal tissue regeneration; and regenerated cartilage sheet for the treatment of osteoarthritis.